covid
Buscar en
Revista Colombiana de Cardiología
Toda la web
Inicio Revista Colombiana de Cardiología Acondicionamiento cardiaco: “más allá de la reperfusión”
Información de la revista
Vol. 20. Núm. 4.
Páginas 223-229 (julio - agosto 2013)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 20. Núm. 4.
Páginas 223-229 (julio - agosto 2013)
Open Access
Acondicionamiento cardiaco: “más allá de la reperfusión”
Cardiac conditioning: “beyond reperfusion”
Visitas
4759
Nelson L. Moreno1,
Autor para correspondencia
neldoctor@yahoo.com

Correspondencia.
1 Cardiología, Universidad Militar Nueva Granada. Bogotá, Colombia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas

Hace más de cuarenta años se describió el posible daño relacionado con la reperfusión, el cual podría explicar hasta el 50% del área total infartada. A finales de los ochenta se describió un mecanismo innato de protección frente a la lesión por isquemia-reperfusión, que se denominó acondicionamiento isquémico. En las últimas décadas, no sólo se han descrito diversos tipos de acondicionamiento sino que se han llevado a cabo experimentos clínicos en humanos, con resultados iniciales alentadores en cuanto a reducción del área infartada. Sin embargo, aún falta por demostrar si la reducción de la lesión por reperfusión tiene impacto en la mortalidad; las investigaciones actuales permitirán aclarar este interrogante en un futuro cercano.

Palabras clave:
injuria por reperfusión
acondicionamiento cardiaco
cardioprotección

The potential damage associated with reperfusion, which could explain up to 50% of the total area infarcted was described over fourty years ago. An innate mechanism of protection against ischemiareperfusion injury was described in the late 80's which was called ischemic conditioning. Not just various types of conditioning have been described in the last decades, but also human clinical experiments with encouraging initial results in the reduction of the infarcted area have been conducted. However, it is not still demonstrated whether the reduction of reperfusion injury has an impact on mortality. The current research will allow to clarify this unanswered question in the near future.

Key words:
reperfusion
ischemic heart disease
acute myocardial infarction
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.B. Herrick.
Certain clinical features of sudden obstruction of the coronary arteries.
JAMA, 59 (1912), pp. 2015-2020
[2.]
D.G. Julian.
Treatment of cardiac arrest in acute myocardial ischemia and infarction.
Lancet, (1961), pp. 840-844
[3.]
R.B. Jennings, H.M. Sommers, G.A. Smyth.
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.
Arch Pathol, 70 (1960), pp. 68
[4.]
C.E. Murry, R.B. Jennings, K.A. Reimer.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation, 74 (1986), pp. 1124-1136
[5.]
E. Braunwald.
The treatment of acute myocardial infarction: the past, the present, and the future.
Eur Heart J Acute Cardiovascular Care, 1 (2012), pp. 9-12
[6.]
D. Yellon, D.J. Hausenloy.
Myocardial reperfusion injury.
N Engl J Med, 357 (2007), pp. 1121-1135
[7.]
R.B. Jennings, H.M. Sommers, G.A. Smyth.
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.
Arch Pathol, 70 (1960), pp. 68
[8.]
E. Braunwald, R.A. Kloner.
Myocardial reperfusion: a double-edged sword?.
J Clin Invest, 76 (1985), pp. 1713-1719
[9.]
A.N.E. Zimmerman, W. Daems, W.C. Hulsmann, J. Snijder, E. Wisse, et al.
Morphological changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (calcium paradox).
Cardiovasc Res, 1 (1967), pp. 201-209
[10.]
D.J. Hearse, S.M. Humphrey, E.B. Chain.
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release.
J Mol Cell Cardiol, 5 (1973), pp. 395-407
[11.]
J.J. Lemasters, J.M. Bond, E. Chacon, I.S. Harper, S.H. Kaplan, et al.
The pH paradox in ischemia reperfusion injury to cardiac myocytes.
EXS, 76 (1996), pp. 99-114
[12.]
J. Vinten-Johansen.
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Cardiovasc Res, 61 (2004), pp. 481-497
[13.]
A. Turer, J. Hill.
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
Am J Cardiol, 106 (2010), pp. 360-368
[14.]
G. Heusch.
Cardioprotection: chances and challenges of its translation to the clinic.
[15.]
K. Przyklenk, B. Bauer, M. Ovize, R.A. Kloner, P. Whittaker.
Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion.
Circulation, 87 (1993), pp. 893-899
[16.]
Y. Birnbaum, S.L. Hale, R.A. Kloner.
Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit.
Circulation, 96 (1997), pp. 1641-1646
[17.]
M.R. Schmidt, M. Smerup, I.E. Konstantinov, M. Shimizu, J. Li, M. Cheung, et al.
Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning.
Am J Physiol Heart Circ Physiol, 292 (2007), pp. H1883-H1890
[18.]
M. Orize, G. Baxter, F. Lisa, P. Ferdinandy, D. Dorado, D. Hausenloy, et al.
Postconditioning and protection from reperfusion injury: where do we stand?.
Cardiovascular Research, 87 (2010), pp. 406-423
[19.]
S. Lavi, R. lavi.
Conditioning of the heart: from pharmacological interventions to local and remote protection.
Int J Cardiol, 146 (2011), pp. 311-318
[20.]
H.E. Bøtker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, C.J. Terkelsen, et al.
Remote ischaemic conditioning before hospital admission, as a complement toangioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.
[21.]
M.S. Marber, D.S. Latchman, J.M. Walker, D.M. Yellon.
Cardiac stress protein elevation 24 hours after brief ischemia or heart stress is associated with resistance to myocardial infarction.
Circulation, 88 (1993), pp. 1264-1272
[22.]
R. Kharbanda, T. Nielsen, A. Redington.
Translation to remote ischaemic preconditioning into clinical practice.
Lancet, 374 (2009), pp. 1557-1565
[23.]
J. Johansen, W. Shi.
Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
J Cardiovasc Pharmacol Therapeutics, 16 (2011), pp. 260-266
[24.]
D.R. Hunter, R.A. Haworth.
The Ca2+-induced membrane transition in mitochondria I. The protective mechanisms.
Arch Biochem Biophys, 195 (1979), pp. 453-459
[25.]
M.M. Cheung, R.K. Kharbanda, I.E. Konstantinov, M. Shimizu, H. Frnduva, M. Li, et al.
Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans.
J Am Coll Cardiol, 47 (2006), pp. 2277-2282
[26.]
D.J. Hausenloy, P.K. Mwamure, V. Venugopal, J. Harris, M. Barnard, E. Grundy, et al.
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.
[27.]
Z.A. Ali, C.J. Callaghan, E. Lim, A.A. Ali, S.A. Nouraei, A.M. Akthar, et al.
Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial.
Circulation, 116 (2007), pp. I98-I105
[28.]
S. Hoole, P. Heck, L. Sharples, S. Khon, R. Duehmke, C. Densem, et al.
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.
Circulation, 119 (2009), pp. 820-827
[29.]
P. Staat, G. Rioufol, C. Piot, Y. Cuttin, T. Cung, I. L'Huillier, et al.
Postconditioning the human heart.
Circulation, 112 (2005), pp. 2143-2148
[30.]
X. Freixa, N. Bellera, J.T. Ortiz-Pérez, M. Jiménez, C. Pare', X. Bosch, et al.
Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention.
Eur Heart J, 33 (2012), pp. 103-112
[31.]
J. Lonborg, H. Kelbaek, N. Vejlstrup, E. Jorgensen, S. Helqvist, K. Saunamaki, et al.
Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.
Circ Cardiovasc Interv, 3 (2010), pp. 34-41
[32.]
W. Shi, J. Johansen.
Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.
Cardiovascular Research, 94 (2012), pp. 206-216
[33.]
I. Rentoukas, G. Giannopoulos, A. Kaoukis, C. Kossyvakis, K. Raisakis, M. Driva, et al.
Cardioprotective role of remote ischemic perconditioning in primary percutaneous coronary intervention: enhancement by opioid action.
JACC Cardiovasc Interv, 3 (2010), pp. 49-55
[34.]
D. Brevoord, P. Kranke, M. Kuijpers, N. Weber, M. Hollmann, B. Preckel.
Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis.
[35.]
K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M. Dicardi, M. Leesar, K. Browne, et al.
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial.
J Am Coll Cardiol, 34 (1999), pp. 1711-1720
[36.]
A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, R.W. Alexander, for the AMISTAD-II Investigators.
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
J Am Coll Cardiol, 45 (2005), pp. 1775-1780
[37.]
M. Kitakaze, M. Asakura, J. Kim.
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
Lancet, 370 (2007), pp. 1483-1493
[38.]
M. Crompton, H. Ellinger, A. Costi.
Inhibition by cyclosporine A of a Ca2+- dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress.
Biochem J, 255 (1988), pp. 357-360
[39.]
C. Piot, P. Croisille, P. Staat, H. Thibaul, G. Riouful, N. Mewton, et al.
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
N Engl J Med, 359 (2008), pp. 473-481
[40.]
M. Riess, D. Stowe, D. Warltier.
Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?.
Am J Physiol Heart Circ Physiol, 286 (2004), pp. H1603-H1607
[41.]
J. Symons, P. Myles.
Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery.
a meta-analysis British J Anaesthesia, 97 (2006), pp. 127-136
[42.]
D.J. Hausenloy, L. Candilio, C. Laing.
Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.
Clin Res Cardiol, 101 (2011), pp. 339-348
Copyright © 2013. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
Descargar PDF
Opciones de artículo
Quizás le interese:
10.1016/j.rccar.2020.06.001
No mostrar más